Linked Life Data

17398133

Source:http://linkedlifedata.com/resource/pubmed/id/17398133

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2007-5-4
pubmed:abstractText
Malaria vaccine development has so far been largely focused on antigens involved in parasite invasion pathways rather than on antigens associated with severe disease and naturally acquired immunity. Individuals repeatedly exposed to Plasmodium falciparum will eventually become immune to severe disease. Parasite-derived antigens expressed on the infected red blood cell (iRBC) surface are the main targets of protective immunity and can be explored as a rational alternative in development of an anti-malaria vaccine.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1286-4579
pubmed:author
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
777-83
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
The naturally acquired immunity in severe malaria and its implication for a PfEMP-1 based vaccine.
pubmed:affiliation
Department of Parasitology, Mycology and Environmental Microbiology, Swedish Institute for Infectious Disease Control, Sweden. qijun.chen@smi.ki.se
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't